Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.

Angewandte Chemie (International ed. in English) - 16 Jan 2004

Müller Oliver, Gourzoulidou Eleni, Carpintero Mercedes, Karaguni Ioanna-Maria, Langerak Anette, Herrmann Christian, Möröy Tarik, Klein-Hitpass Ludger, Waldmann Herbert

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Annexin A5
Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Cell Line, Transformed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combinatorial Chemistry Techniques

Share to Drug Screening Assays, Antitumor

Share to Inhibitory Concentration 50

Share to Wnt Proteins

Share to Zebrafish Proteins

Source

Identifiers

PMID: 14735532
DOI: 10.1002/anie.200352587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.PMID 14735532Read ↗

Development of small-molecule probes that selectively kill cells induced to express mutant RAS.Semantic proximity Read ↗

Inhibition of Ras for cancer treatment: the search continues.Semantic proximity Read ↗

Ras proteins as therapeutic targets.Semantic proximity Read ↗

Inhibitors of the ERK mitogen-activated protein kinase cascade for targeting RAS mutant cancers.Semantic proximity Read ↗

Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular Context.Semantic proximity Read ↗

Past, Present, and Future of Targeting Ras for Cancer Therapies.Semantic proximity Read ↗

Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.Semantic proximity Read ↗

The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies.Semantic proximity Read ↗

Dominant Negative RAS as an anticancer agent.Semantic proximity Read ↗

Targeting the "undruggable" RAS with biologics.Semantic proximity Read ↗

A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype.Semantic proximity Read ↗

Genetic and pharmacologic dissection of Ras effector utilization in oncogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.